Erratum to: A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study
Valle, Juan W
AffiliationUCL Cancer Institute, 72 Huntley St, London, WC1E 6DD, UK
MetadataShow full item record
CitationErratum to: A phase 1b study of Selumetinib in combination with Cisplatin and Gemcitabine in advanced or metastatic biliary tract cancer: the ABC-04 study. 16 (1):369 BMC Cancer
TypeMeetings and Proceedings
- Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial.
- Authors: Valle JW, Wasan H, Lopes A, Backen AC, Palmer DH, Morris K, Duggan M, Cunningham D, Anthoney DA, Corrie P, Madhusudan S, Maraveyas A, Ross PJ, Waters JS, Steward WP, Rees C, Beare S, Dive C, Bridgewater JA
- Issue date: 2015 Aug
- Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.
- Authors: Weigt J, Malfertheiner P
- Issue date: 2010 Aug
- Cisplatin and gemcitabine in patients with advanced biliary tract cancer (ABC) and persistent jaundice despite optimal stenting: Effective intervention in patients with luminal disease.
- Authors: Lamarca A, Benafif S, Ross P, Bridgewater J, Valle JW
- Issue date: 2015 Sep
- A retrospective study of chemotherapy with cisplatin plus gemcitabine after the failure of gemcitabine monotherapy for biliary tract cancer.
- Authors: Kameda R, Ando T, Kobayashi S, Ueno M, Ohkawa S
- Issue date: 2013 Jun
- Phase I trial of combination chemotherapy with gemcitabine, cisplatin, and S-1 in patients with advanced biliary tract cancer.
- Authors: Watanabe A, Kida M, Miyazawa S, Iwai T, Okuwaki K, Kaneko T, Yamauchi H, Takezawa M, Imaizumi H, Koizumi W
- Issue date: 2015 May 21